Statements of Cash Flows - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2019
Cash flow from operating activities
Net income (loss)	$ (2,516)	$ 167,472
Adjustments to reconcile net income (loss) to net cash used in operating activities
Interest income earned in cash and investments held in trust account		(505,858)
Change in operating assets and liabilities:
Increase in prepayments		(26,016)
Increase in accrued liabilities		9,255
Cash used in operating activities	(2,516)	(355,147)
Cash flows from investing activities
Proceeds deposited in Trust Account		(46,000,015)
Net cash used in investing activities		(46,000,015)
Cash flows from financing activities
Proceeds from unit purchase option		100
Proceeds from public offering, net of offering cost		44,538,719
Proceeds from sale of private placement		2,250,000
Proceeds from issuance of ordinary shares to Initial Shareholder	1	25,000
Advances from a related party	72,515	470,678
Payment of offering costs	(70,000)
Net cash provided by financing activities	2,516	47,284,497
NET CHANGE IN CASH AND CASH EQUIVALENT		929,335
Cash and cash equivalent, beginning of year/period
Cash and cash equivalent, end of year/period		929,335
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Deferred offering costs included in accrued offering costs	2,500
Initial classification of shares subject to conversion		40,702,622
Change in value of shares subject to conversion		275,808
Deferred underwriting compensation		$ 1,025,948